BEIJING, May 7, 2012 /PRNewswire-Asia-FirstCall/
-- Dehaier Medical Systems Ltd. (Nasdaq: DHRM)
("Dehaier" or the "Company"), an emerging leader in the
development, assembly, marketing and sale of medical devices and
homecare medical products, today announced that it will release
financial results for its first quarter ended March 31, 2012 on Wednesday, May 9th, 2012 after close of the
trading in the United States.
(Logo: http://photos.prnewswire.com/prnh/20100422/CNTH001LOGO
)
Company management will host a conference call for investors in
the following morning on Thursday, May 10th,
2012 at 8:30 a.m. EDT.
Interested parties may access the call by dialing:
Live Participant Dial In
(Toll Free):
|
877-407-8033
|
Live Participant Dial In
(International – Country Code - 001):
|
201-689-8033
|
For those unable to participate, the call will be available as a
live, listen-only webcast on the Company's website at
http://www.dehaier.com.cn or by clicking the following link:
http://www.investorcalendar.com/IC/CEPage.asp?ID=168495
About Dehaier Medical Systems Ltd.
Dehaier is an emerging leader in the development, assembly,
marketing and sale of medical products, including respiratory and
oxygen homecare medical products. The company develops and
assembles its own branded medical devices and homecare medical
products from third-party components. The company also distributes
products designed and manufactured by other companies, including
medical devices from IMD (Italy),
HEYER (Germany), Timesco (UK) and
eVent Medical (US). Dehaier's technology is based on six patents
and five software copyrights; additionally Dehaier has two pending
software copyrights and proprietary technology. More information
may be found at http://www.dehaier.com.cn.
Forward-looking Statements
This news release contains forward-looking statements as defined
by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events, government approvals
or performance, and underlying assumptions and other statements
that are other than statements of historical facts, including in
particular statements about Dehaier's membership in the
Zhongguancun Association and the meaning of and retention of any
ratings granted to Dehaier (including any factors affecting such
ratings). These statements are subject to uncertainties and risks
including, but not limited to, product and service demand and
acceptance, changes in technology, economic conditions, the impact
of competition and pricing, government regulation, future
developments in payment for and demand for medical equipment and
services, implementation of and performance under the joint venture
agreement by all parties, and other risks contained in reports
filed by the company with the Securities and Exchange Commission.
All such forward-looking statements, whether written or oral, and
whether made by or on behalf of the company, are expressly
qualified by the cautionary statements and any other cautionary
statements which may accompany the forward-looking statements. In
addition, the company disclaims any obligation to update any
forward-looking statements to reflect events or circumstances after
the date hereof.
Contact Us
Dehaier Medical Systems Limited
Surie Liu
+86 10-5166-0080
lius@dehaier.com.cn
Dehaier Medical Systems Limited
Tina He
+86 10-5166-0080
hexw@dehaier.com.cn
The Equity Group Inc.
Katherine Yao
+86 10-6587-6435
kyao@equityny.com
In America
The Equity Group Inc.
Adam Prior
(212) 836-9606
aprior@equityny.com
SOURCE Dehaier Medical Systems Ltd.